A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Sulfacytine
Tiapride
Canagliflozin may increase the excretion rate of Tiapride which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Benserazide
Canagliflozin may increase the excretion rate of Benserazide which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Propiverine
Canagliflozin may increase the excretion rate of Propiverine which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Deutetrabenazine
Canagliflozin may increase the excretion rate of Deutetrabenazine which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Vaborbactam
Canagliflozin may increase the excretion rate of Vaborbactam which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Isoflavone
Canagliflozin may increase the excretion rate of Isoflavone which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Benznidazole
Canagliflozin may increase the excretion rate of Benznidazole which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Valbenazine
Canagliflozin may increase the excretion rate of Valbenazine which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Tropisetron
Canagliflozin may increase the excretion rate of Tropisetron which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Naldemedine
Canagliflozin may increase the excretion rate of Naldemedine which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Antithrombin III human
Canagliflozin may increase the excretion rate of Antithrombin III human which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Etafedrine
Canagliflozin may increase the excretion rate of Etafedrine which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Indigotindisulfonic acid
Canagliflozin may increase the excretion rate of Indigotindisulfonic acid which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Lesinurad
Canagliflozin may increase the excretion rate of Lesinurad which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Pidotimod
Canagliflozin may increase the excretion rate of Pidotimod which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Evening primrose oil
Canagliflozin may increase the excretion rate of Evening primrose oil which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Clove oil
Canagliflozin may increase the excretion rate of Clove oil which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Tetradecyl hydrogen sulfate (ester)
Canagliflozin may increase the excretion rate of Tetradecyl hydrogen sulfate (ester) which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
DL-Methylephedrine
Canagliflozin may increase the excretion rate of DL-Methylephedrine which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Tocopherol
Canagliflozin may increase the excretion rate of Tocopherol which could result in a lower serum level and potentially a reduction in efficacy.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3